What We're Reading: US to Ship 80M Vaccines; Cyberattack on Irish Health Care; Recall of Abbott Pacemakers
The United States will ship approximately 80 million excess doses of COVID-19 vaccines abroad; Ireland's health services system could be hobbled for weeks by a ransomware attack; the FDA recalls more than 60,000 pacemakers manufactured by Abbott.
What We're Reading: Nurse Unions Critical of Mask Guidance; Positive Sanofi, GSK Vaccine Results; Georgia Fentanyl Overdoses
Prominent nurse unions are critical of new CDC mask guidance; Sanofi, GlaxoSmithKline announce positive phase 2 results of their joint COVID-19 vaccine; Georgia officials report significant fentanyl overdose rates tied to tainted substances.
Rheumatology Rundown: Pregnancy and Lupus, Attitudes Toward Exercise, and More
Some of the latest rheumatology news includes updates on pregnancy, exercise, and treatment for psoriatic arthritis.
Diabetes in the News: PQA Speakers Focus on Prevention, Gaps in Care
There is a role for pharmacists and pharmacy quality measures in addressing the public health challenge of diabetes, according to speakers at a recent virtual meeting this week.
Latest in Leukemia and Lymphoma: Advancing Treatment in DLBCL
New research is helping to move the field forward for diffuse large B-cell lymphoma (DLBCL).
Psoriasis Recap: Intermittent Fasting, Microbiome-Skin Links, and More
Updates from 2 recent medical meetings about links between the gut, psoriasis, and other skin disease, as well as the risk of COVID-19.
Advancing Precision Medicine in Community Oncology Practice
Despite expanded use of precision medicine, there remain a myriad of barriers hindering its implementation in day-to-day practice.
AJMC® in the Press, May 14, 2021
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
What We’re Reading: Missouri Not Expanding Medicaid; Public Health Worker Hiring; WHO Report Criticized
A voter-passed measure to expand Medicaid coverage in Missouri will not advance; $7.4 billion will soon be available for recruiting and hiring public health workers; the World Health Organization (WHO) is being chastised for its COVID-19 origins report.
What We’re Reading: US COVID-19 Deaths Hit New Low; CDC, FDA Face Trust Problems; Vaccine Disparities in CA
Rates of COVID-19 deaths have fallen to their lowest point in 10 months in the United States; survey reveals America's public health agencies face significant trust barriers; data from California highlight vaccine administration disparities.
What We’re Reading: AMA Issues Antiracism Plan; Reporting Vaccinations at Nursing Homes; Few COVID-19 Patients Carry Community’s Virus
The American Medical Association announces an antiracism plan; CMS requires nursing homes to report vaccination rates; a minority of COVID-19 carriers are responsible for the bulk of a community's virus spread.
What We're Reading: India's High COVID-19 Case Averages; Vaccination Rates Across States; ACA Special Enrollment Period
The 7-day average of new COVID-19 cases in India reaches a record high; vaccination rates of US adults differ significantly depending on the region; 1 million people have enrolled during the special ACA open enrollment period.
Oncology Roundup: Highlights From the ESMO Breast Cancer Virtual Congress
A roundup of cancer news from the ESMO Breast Cancer Virtual Congress 2021, which took place last week and was covered by OncLive®.
What We're Reading: Protections for LGBTQ Against Health Care Discrimination; Airborne COVID-19 Threat; EU, Pfizer Vaccine Deal
HHS announces prohibitions against discriminating by sexual orientation, gender identity in health care; updated CDC guidance highlights airborne threat of COVID-19; European Union, Pfizer/BioNTech agree to deal that could reach 1.8 billion vaccine doses.
Precision Medicine Wrap-up: Using Biomarkers to Guide Therapy in Various Cancers
Biomarkers are being used in patients with cancer to target treatments that will work best. Interviews with OncLive® highlight how biomarkers are being used in colorectal and bladder cancer.
Diabetes in the News: Pregnancy and Diabetes, Dementia Risk, Pediatric Ketoacidosis
A roundup of diabetes news you may have missed from across MJH Life Sciences™.
What We’re Reading: Global COVID-19 Death Toll; Vaccine Efficacy in Teens; Impact of US Patent Waiver
A new analysis finds the global COVID-19 death toll is much higher than previously estimated; data show promising efficacy rates of COVID-19 vaccines in teens; the US COVID-19 vaccine patent waiver may not result in immediate aid to countries.
AJMC® in the Press, May 7, 2021
What We’re Reading: Suspending COVID-19 Vaccine Patents; HIV and Vaccine Efficacy; COVID-19 Cases Projected to Drop by July
The United States agreed to temporarily suspend COVID-19 vaccine patents; HIV does not appear to impact efficacy of AstraZeneca's COVID-19 vaccine; cases of COVID-19 cases could decrease by July.
What We’re Reading: US Birth Rate Drops; Biden Revises Vaccination Goal; PPE Costs Skyrocket During Pandemic
There was an overall 4.3% drop in total US births from 2019 to 2020; the Biden administration wants to increase the COVID-19 vaccination rate among Americans; medical professionals seek reimbursement for personal protective equipment (PPE).
What We’re Reading: Pfizer Vaccine EUA in Adolescents; COVID-19 Restrictions Easing Nationwide; Children Account for Rising Case Rates
The FDA is preparing to authorize the Pfizer/BioNTech COVID-19 vaccine in adolescents aged 12 to 15 years; COVID-19 restrictions on capacity limits are lifting nationwide; children account for more than 1 in 5 new COVID-19 cases.
What We're Reading: Wasted Vaccine Doses at CVS, Walgreens; India Reports Record Daily COVID-19 Cases; Anxiety and J&J Vaccine
Walgreens, CVS responsible for a majority of wasted US COVID-19 vaccine doses; travel to India restricted by Biden administration amid record daily COVID-19 cases; CDC report links physical adverse events to J&J vaccine with anxiety.
Longer PASI90 Duration Associated With Better PROs for Patients With Psoriasis
Each month of duration of 90% or more improvement in Psoriasis Are and Severity Index significantly impacted patient-reported outcomes in patients with psoriasis.
Could Cyltezo Be the First Interchangeable Biosimilar in the United States?
Despite the FDA approving 29 biosimilars, none have achieved interchangeability status. Boehringer Ingelheim thinks its adalimumab biosimilar, Cyltezo, may be the first.
What We’re Reading: CVS Mental Health Counseling; New CMS Rules Adopted; Excess of Cervical Cancer Screening
CVS will expand its pilot mental health program; CMS adopts new rules to lower out-of-pocket costs; a study highlights overuse of cervical cancer screening tests.
What We’re Reading: Biden Pushes Health Initiatives; Air Pollution’s Impact on Americans of Color; US COVID-19 Cases Drop
President Biden outlined new health initiatives in his first speech to a joint session of Congress; data show the disproportionate impact of air pollution on communities of color; COVID-19 case rates decline in half of US states.
Dostarlimab, Diagnostic Cleared for Advanced Endometrial Cancer With Specific Biomarker
Dostarlimab, for patients with recurrent or advanced deficient mismatch repair endometrial cancer, and a companion diagnostic, were recently approved by the FDA.
Zanubrutinib Shows Positive Results in Interim Analysis Against Ibrutinib in CLL
Besides demonstrating noninferiority in objective response rates, zanubrutinib also showed a statistically significant lower risk of atrial fibrillation or flutter compared with ibrutinib.
What We’re Reading: Opioids Prescribed to COVID-19 Patients; Pitfalls of Indoor Social Distancing; IBD Drug, Vaccine Interaction
Patients with long COVID-19 at Veterans Health Administration facilities are being prescribed more addictive medications; indoor social distancing may provide a false sense of security; a drug for inflammatory bowel disease may blunt COVID-19 vaccine efficacy.
What We’re Reading: US to Share 60M Vaccine Doses Worldwide; COVID-19 Workplace Safety Rules; No Action on Drug Pricing
The United States will distribute 60 million doses of the AstraZeneca COVID-19 vaccine to other countries over the next several months; workplace safety rules on COVID-19 submitted by Labor Department for review; White House reportedly will not include measures targeting drug prices in antipoverty package.